BCT BriaCell Therapeutics Corp.

3.077USD4.400 CAD · TSX-5.48%Mkt Cap: 26.87M USDP/E: —

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against…